Dimethylarginines in patients with intracerebral hemorrhage: association with outcome, hematoma enlargement, and edema

BACKGROUND: Asymmetric dimethylarginine (ADMA)––the most potent endogenous NO-synthase inhibitor, has been regarded as mediator of endothelial dysfunction and oxidative stress. Considering experimental data, levels of ADMA and its structural isomer symmetric dimethylarginine (SDMA) might be elevated...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Neuroinflammation
Huvudupphovsmän: Worthmann, Hans, Li, Na, Martens-Lobenhoffer, Jens, Dirks, Meike, Schuppner, Ramona, Lichtinghagen, Ralf, Kielstein, Jan T., Raab, Peter, Lanfermann, Heinrich, Bode-Böger, Stefanie M., Weissenborn, Karin
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2017
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729507/
https://ncbi.nlm.nih.gov/pubmed/29237474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12974-017-1016-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk